MGAT3 and melanoma: Further on, the same group showed that in those GnT-III transfectants from mouse melanoma cells, E-cadherin was modified with bisecting GlcNAc structures showing a delayed turnover rate and an increased cell-cell adhesion, which might explain the metastatic impairment induced by GnT-III overexpression [12].